Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This partially randomized pilot phase I trial studies how much sapanisertib reaches the brain
tumor and how well it works when given before and after surgery in treating patients with
glioblastoma that has grown or come back and requires surgery. Sapanisertib may stop the
growth of tumor cells by blocking some of the enzymes needed for cell growth.